IDEAS home Printed from https://ideas.repec.org/a/bla/biomet/v57y2001i1p158-167.html
   My bibliography  Save this article

Bayesian Approaches to Modeling the Conditional Dependence Between Multiple Diagnostic Tests

Author

Listed:
  • Nandini Dendukuri
  • Lawrence Joseph

Abstract

Summary. Many analyses of results from multiple diagnostic tests assume the tests are statistically independent conditional on the true disease status of the subject. This assumption may be violated in practice, especially in situations where none of the tests is a perfectly accurate gold standard. Classical inference for models accounting for the conditional dependence between tests requires that results from at least four different tests be used in order to obtain an identifiable solution, but it is not always feasible to have results from this many tests. We use a Bayesian approach to draw inferences about the disease prevalence and test properties while adjusting for the possibility of conditional dependence between tests, particularly when we have only two tests. We propose both fixed and random effects models. Since with fewer than four tests the problem is nonidentifiable, the posterior distributions are strongly dependent on the prior information about the test properties and the disease prevalence, even with large sample sizes. If the degree of correlation between the tests is known a priori with high precision, then our methods adjust for the dependence between the tests. Otherwise, our methods provide adjusted inferences that incorporate all of the uncertainty inherent in the problem, typically resulting in wider interval estimates. We illustrate our methods using data from a study on the prevalence of Strongyloides infection among Cambodian refugees to Canada.

Suggested Citation

  • Nandini Dendukuri & Lawrence Joseph, 2001. "Bayesian Approaches to Modeling the Conditional Dependence Between Multiple Diagnostic Tests," Biometrics, The International Biometric Society, vol. 57(1), pages 158-167, March.
  • Handle: RePEc:bla:biomet:v:57:y:2001:i:1:p:158-167
    DOI: 10.1111/j.0006-341X.2001.00158.x
    as

    Download full text from publisher

    File URL: https://doi.org/10.1111/j.0006-341X.2001.00158.x
    Download Restriction: no

    File URL: https://libkey.io/10.1111/j.0006-341X.2001.00158.x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. David J. Spiegelhalter & Laurence S. Freedman & Mahesh K. B. Parmar, 1994. "Bayesian Approaches to Randomized Trials," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 157(3), pages 357-387, May.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Leandro García Barrado & Els Coart & Tomasz Burzykowski, 2017. "Estimation of diagnostic accuracy of a combination of continuous biomarkers allowing for conditional dependence between the biomarkers and the imperfect reference-test," Biometrics, The International Biometric Society, vol. 73(2), pages 646-655, June.
    2. Scott Weichenthal & Lawrence Joseph & Patrick Bélisle & André Dufresne, 2010. "Bayesian Estimation of the Probability of Asbestos Exposure from Lung Fiber Counts," Biometrics, The International Biometric Society, vol. 66(2), pages 603-612, June.
    3. Min Zhang & Chong Wang & Annette O’Connor, 2021. "A Bayesian approach to modeling antimicrobial multidrug resistance," PLOS ONE, Public Library of Science, vol. 16(12), pages 1-14, December.
    4. Beavers, Daniel P. & Stamey, James D., 2012. "Bayesian sample size determination for binary regression with a misclassified covariate and no gold standard," Computational Statistics & Data Analysis, Elsevier, vol. 56(8), pages 2574-2582.
    5. Geoffrey Jones & Wesley O. Johnson, 2016. "A Bayesian Superpopulation Approach to Inference for Finite Populations Based on Imperfect Diagnostic Outcomes," Journal of Agricultural, Biological and Environmental Statistics, Springer;The International Biometric Society;American Statistical Association, vol. 21(2), pages 314-327, June.
    6. Gustafson Paul, 2010. "Bayesian Inference for Partially Identified Models," The International Journal of Biostatistics, De Gruyter, vol. 6(2), pages 1-20, March.
    7. O’Neill, Donal, 2015. "Measuring obesity in the absence of a gold standard," Economics & Human Biology, Elsevier, vol. 17(C), pages 116-128.
    8. Paul S. Albert & Lori E. Dodd, 2004. "A Cautionary Note on the Robustness of Latent Class Models for Estimating Diagnostic Error without a Gold Standard," Biometrics, The International Biometric Society, vol. 60(2), pages 427-435, June.
    9. Shahieda Adams & Rodney Ehrlich & Roslynn Baatjies & Nandini Dendukuri & Zhuoyu Wang & Keertan Dheda, 2019. "Evaluating Latent Tuberculosis Infection Test Performance Using Latent Class Analysis in a TB and HIV Endemic Setting," IJERPH, MDPI, vol. 16(16), pages 1-11, August.
    10. Nandini Dendukuri & Elham Rahme & Patrick Bélisle & Lawrence Joseph, 2004. "Bayesian Sample Size Determination for Prevalence and Diagnostic Test Studies in the Absence of a Gold Standard Test," Biometrics, The International Biometric Society, vol. 60(2), pages 388-397, June.
    11. Adam J. Branscum & Dunlei Cheng & J. Jack Lee, 2015. "Testing hypotheses about medical test accuracy: considerations for design and inference," Journal of Applied Statistics, Taylor & Francis Journals, vol. 42(5), pages 1106-1119, May.
    12. Paul Gustafson & Sander Greenland, 2006. "The Performance of Random Coefficient Regression in Accounting for Residual Confounding," Biometrics, The International Biometric Society, vol. 62(3), pages 760-768, September.
    13. Hae-Young Kim & Michael G. Hudgens & Jonathan M. Dreyfuss & Daniel J. Westreich & Christopher D. Pilcher, 2007. "Comparison of Group Testing Algorithms for Case Identification in the Presence of Test Error," Biometrics, The International Biometric Society, vol. 63(4), pages 1152-1163, December.
    14. Fabio Principato & Angela Vullo & Domenica Matranga, 2010. "On implementation of the Gibbs sampler for estimating the accuracy of multiple diagnostic tests," Journal of Applied Statistics, Taylor & Francis Journals, vol. 37(8), pages 1335-1354.
    15. Nandini Dendukuri & Ian Schiller & Lawrence Joseph & Madhukar Pai, 2012. "Bayesian Meta-Analysis of the Accuracy of a Test for Tuberculous Pleuritis in the Absence of a Gold Standard Reference," Biometrics, The International Biometric Society, vol. 68(4), pages 1285-1293, December.
    16. Stamey, James D. & Boese, Doyle H. & Young, Dean M., 2008. "Confidence intervals for parameters of two diagnostic tests in the absence of a gold standard," Computational Statistics & Data Analysis, Elsevier, vol. 52(3), pages 1335-1346, January.
    17. Geoffrey Jones & Wesley O. Johnson & Timothy E. Hanson & Ronald Christensen, 2010. "Identifiability of Models for Multiple Diagnostic Testing in the Absence of a Gold Standard," Biometrics, The International Biometric Society, vol. 66(3), pages 855-863, September.
    18. Martin Ladouceur & Elham Rahme & Christian A. Pineau & Lawrence Joseph, 2007. "Robustness of Prevalence Estimates Derived from Misclassified Data from Administrative Databases," Biometrics, The International Biometric Society, vol. 63(1), pages 272-279, March.
    19. Elizabeth R. Brown, 2010. "Bayesian Estimation of the Time-Varying Sensitivity of a Diagnostic Test with Application to Mother-to-Child Transmission of HIV," Biometrics, The International Biometric Society, vol. 66(4), pages 1266-1274, December.
    20. Adam Branscum & Timothy Hanson & Ian Gardner, 2008. "Bayesian non-parametric models for regional prevalence estimation," Journal of Applied Statistics, Taylor & Francis Journals, vol. 35(5), pages 567-582.
    21. Caitlin Ward & Grant D. Brown & Jacob J. Oleson, 2023. "An individual level infectious disease model in the presence of uncertainty from multiple, imperfect diagnostic tests," Biometrics, The International Biometric Society, vol. 79(1), pages 426-436, March.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Francesco De Pretis & Barbara Osimani, 2019. "New Insights in Computational Methods for Pharmacovigilance: E-Synthesis , a Bayesian Framework for Causal Assessment," IJERPH, MDPI, vol. 16(12), pages 1-19, June.
    2. Charles F. Manski, 2018. "Reasonable patient care under uncertainty," Health Economics, John Wiley & Sons, Ltd., vol. 27(10), pages 1397-1421, October.
    3. Paul Gustafson & Nhu D. Le & Refik Saskin, 2001. "Case–Control Analysis with Partial Knowledge of Exposure Misclassification Probabilities," Biometrics, The International Biometric Society, vol. 57(2), pages 598-609, June.
    4. Charles F. Manski, 2021. "Econometrics for Decision Making: Building Foundations Sketched by Haavelmo and Wald," Econometrica, Econometric Society, vol. 89(6), pages 2827-2853, November.
    5. Charles F. Manski & Aleksey Tetenov, 2015. "Clinical trial design enabling ε-optimal treatment rules," CeMMAP working papers 60/15, Institute for Fiscal Studies.
    6. Isakov, Leah & Lo, Andrew W. & Montazerhodjat, Vahid, 2019. "Is the FDA too conservative or too aggressive?: A Bayesian decision analysis of clinical trial design," Journal of Econometrics, Elsevier, vol. 211(1), pages 117-136.
    7. Jingjing Ye & Gregory Reaman, 2022. "Improving Early Futility Determination by Learning from External Data in Pediatric Cancer Clinical Trials," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 14(2), pages 337-351, July.
    8. Kruschke, John K. & Liddell, Torrin, 2016. "The Bayesian New Statistics: Hypothesis testing, estimation, meta-analysis, and power analysis from a Bayesian perspective," OSF Preprints ksfyr, Center for Open Science.
    9. Bradley P. Carlin & James S. Hodges, 1999. "Hierarchical Proportional Hazards Regression Models for Highly Stratified Data," Biometrics, The International Biometric Society, vol. 55(4), pages 1162-1170, December.
    10. Karl Claxton & John Posnett, 1996. "An economic approach to clinical trial design and research priority‐setting," Health Economics, John Wiley & Sons, Ltd., vol. 5(6), pages 513-524, November.
    11. Norman Simón Rodríguez Cano, 2018. "Tendencias actuales en la evaluación de políticas públicas," Ensayos de Economía 17296, Universidad Nacional de Colombia Sede Medellín.
    12. Francisco-José Polo & Miguel Negrín & Xavier Badía & Montse Roset, 2005. "Bayesian regression models for cost-effectiveness analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(1), pages 45-52, March.
    13. Danila Azzolina & Giulia Lorenzoni & Silvia Bressan & Liviana Da Dalt & Ileana Baldi & Dario Gregori, 2021. "Handling Poor Accrual in Pediatric Trials: A Simulation Study Using a Bayesian Approach," IJERPH, MDPI, vol. 18(4), pages 1-16, February.
    14. Martin E. Backhouse, 1998. "An investment appraisal approach to clinical trial design," Health Economics, John Wiley & Sons, Ltd., vol. 7(7), pages 605-619, November.
    15. James C. Felli & Gordon B. Hazen, 1998. "Sensitivity Analysis and the Expected Value of Perfect Information," Medical Decision Making, , vol. 18(1), pages 95-109, January.
    16. Peter F. Thall & Richard M. Simon & Yu Shen, 2000. "Approximate Bayesian Evaluation of Multiple Treatment Effects," Biometrics, The International Biometric Society, vol. 56(1), pages 213-219, March.
    17. David M. Rindskopf & William R. Shadish & M. H. Clark, 2018. "Using Bayesian Correspondence Criteria to Compare Results From a Randomized Experiment and a Quasi-Experiment Allowing Self-Selection," Evaluation Review, , vol. 42(2), pages 248-280, April.
    18. Miguel A. Negrín & Francisco J. Vázquez-Polo & María Martel & Elías Moreno & Francisco J. Girón, 2010. "Bayesian Variable Selection in Cost-Effectiveness Analysis," IJERPH, MDPI, vol. 7(4), pages 1-20, April.
    19. Leonhard Held, 2020. "A new standard for the analysis and design of replication studies," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 183(2), pages 431-448, February.
    20. Charles F. Manski, 2017. "Improving Clinical Guidelines and Decisions under Uncertainty," NBER Working Papers 23915, National Bureau of Economic Research, Inc.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bla:biomet:v:57:y:2001:i:1:p:158-167. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www.blackwellpublishing.com/journal.asp?ref=0006-341X .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.